New AI-driven platform enhances lung cancer tissue analysis

FHS
August 23, 2024
10:48 pm

A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence.

Inflammatix raises $57M to advance test for infection, sepsis

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Inflammatix raised $57 million to

September 13, 2024

UVA scientists’ efforts could help better combat antibiotic-resistant bacteria

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could

October 12, 2023

New immunotherapy approach shows promise for minimizing spinal cord injury damage

WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune cells.

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.